Bibliographical noteFunding Information:
Acknowledgements. We thank the dedicated staff of the RASS trial. Minneapolis: J. Basgen, Morphometry Lab Supervisor; A. Palmer, T. Grop-poli, S. Rozen and P. Herbert, Electron Microscopists; J. Bucksa, Central Biochemistry Lab Mgr; M. Nowicki, Central Lab Lead Tech; K. Sawyer, Central Albumin Lab Jr Scientist; B. Chavers, Central Albumin Lab Director; S. Kupcho, Central Albumin Lab Supervisor; B. Lohr, Pharmacy Clinical Specialist; D. Luke, Pharmacy Coordinator; K. Johnson, Pharmacist; P. Stanitis and M. Cohen, Fundus Photographers; J. Stein, Asst Project Manager; J. Pederson, Asst Trial Coordinator. We also thank the Minnesota GCRC staff. Montreal: D. Laforte, Trial Coordinator; G. Carro-Ciampi, Pharmacy Coordinator; L. Marcon, Fundus Photographer; B. Maruca, Research Assistant; A. Roy, Research Nurse. Toronto: A. Barnie, Trial Co-ordinator; K. Bowyer, A. Roode, E. Vivero, Research Nurses; L. Tuason, Administrative Assistant. Montreal Data Center: D. Gaudreau, Administrative Asst; C. Hebert, Coordinator; V. Lucas, Data Entry; M. Senecal and C. Delaney. We are truly grateful to the patients who volunteered for this study. Funding is provided by National Institutes of Health (NIH) (DK51975); Merck & Co., USA; Merck Frosst, Canada; and Canadian Institutes of Health Research (CIHR) (DCT 14281). The University of Minnesota General Clinical Research Center (GCRC) is supported by NIH (M01 RR 00400).
- Biopty™ needle
- Diabetic nephropathy
- Renal biopsy
- Vim-Silverman needle